Trial Summary
What is the purpose of this trial?The goal of this study is to implement Opioid Use Disorder Quality Measurement and Management (OUD-QM2) strategy by the Office of Addiction Services and Supports (OASAS) to drive change and improve treatment practices. Through a concurrent mixed methods approach that iteratively examines quantitative and qualitative data to inform the process, the investigators will examine the effects of the strategy on stakeholders-PWUD/patients, families, and providers-and outcomes. This comprehensive approach will allow for a "global" view of the perceived effects of the OUD-QM2 strategy for all stakeholders while allowing us to use administrative data to test the effects of the strategy on patient outcomes. Through qualitative interviews and focus groups conducted in years 1, 3, and 5 of the phase, the investigators will derive information from stakeholders about their perceptions and use of the quality measures. Through surveys conducted with all clinics, the investigators will elicit data on changes in provider use of quality measures, clinical practice, and use of measures for incentive-based contracting. Finally, the investigators will conduct a stepped wedge trial to examine the effects of performance coaching that guides clinics on use of the quality measures for clinical practice improvement. The trial will also benefit from a treatment as usual (TAU) condition of clinics not participating in the trial to examine secular trends in patient outcomes across the period of the OASAS QM2 strategy rollout. The overall aim is to build and test a science-based OUD-QM2 strategy for person-centered treatment.
Eligibility Criteria
This trial is for stakeholders in the New York State addiction treatment system, including people with opioid use disorder (PWUD), their families, and providers. It aims to assess a quality management strategy's impact on treatment practices and patient outcomes.Inclusion Criteria
Clients and clinicians of people attending substance use treatment programs in New York State with Opioid Use Disorder in the time interval 2020-2027
I am 18 years old or older.
Exclusion Criteria
My gender does not affect my eligibility for this trial.
I am an adult.
Participant Groups
The study tests an Opioid Use Disorder Quality Measurement and Management (OUD-QM2) strategy using performance coaching. The goal is to improve clinical practices in addiction services by guiding clinics through the use of quality measures.
1Treatment groups
Experimental Treatment
Group I: Performance coachingExperimental Treatment1 Intervention
All clinics will receive the performance coaching intervention. There is only one arm to this study.
Find a Clinic Near You
Research Locations NearbySelect from list below to view details:
NYU Langone HealthNew York, NY
Loading ...
Who Is Running the Clinical Trial?
NYU Langone HealthLead Sponsor
National Institute on Drug Abuse (NIDA)Collaborator